Camilla Mattiuzzi1, Fabian Sanchis-Gomar2, Giuseppe Lippi3. 1. Service of Clinical Governance, Provincial Agency for Social and Sanitary Services, Trento, Italy. 2. Department of Physiology, Faculty of Medicine, University of Valencia and INCLIVA Biomedical Research Institute, Valencia, Spain. Electronic address: fabian.sanchis@uv.es. 3. Section of Clinical Biochemistry, University of Verona, Verona, Italy.
Abstract
BACKGROUND AND AIM: an increased value of low-density lipoprotein cholesterol (LDL-C) is now universally considered a major cardiovascular disease (CVD) risk factor. LDL-C is included in the vast majority of worldwide cardiovascular risk prediction algorithms, as well as in the guidelines for cardiovascular risk prevention. We aimed to provide an overview of the worldwide adverse healthcare impact of low-density lipoprotein cholesterol (LDL-C). METHODS AND RESULTS: Data on the epidemiologic burden of LDL-C >1.3 mmol/L were retrieved from Global Health Data Exchange (GHDx) registry. The current burden is 94.92 million disability-adjusted life years (DALYs), with an exponential increase occurred during the past 25 years. 4.32 million deaths can be attributed to LDL cholesterol values > 1.3 mmol/L. DALYs and deaths due to LDL-C have significantly increased in all countries except those with high socio-demographic index. CONCLUSION: More effective structural healthcare policies shall be planned at a worldwide scale for contrasting the epidemics of LDL-C attributable heath loss.
BACKGROUND AND AIM: an increased value of low-density lipoprotein cholesterol (LDL-C) is now universally considered a major cardiovascular disease (CVD) risk factor. LDL-C is included in the vast majority of worldwide cardiovascular risk prediction algorithms, as well as in the guidelines for cardiovascular risk prevention. We aimed to provide an overview of the worldwide adverse healthcare impact of low-density lipoprotein cholesterol (LDL-C). METHODS AND RESULTS: Data on the epidemiologic burden of LDL-C >1.3 mmol/L were retrieved from Global Health Data Exchange (GHDx) registry. The current burden is 94.92 million disability-adjusted life years (DALYs), with an exponential increase occurred during the past 25 years. 4.32 million deaths can be attributed to LDL cholesterol values > 1.3 mmol/L. DALYs and deaths due to LDL-C have significantly increased in all countries except those with high socio-demographic index. CONCLUSION: More effective structural healthcare policies shall be planned at a worldwide scale for contrasting the epidemics of LDL-C attributable heath loss.
Authors: Andreia Machado Miranda; Alessandra Carvalho Goulart; Giuliano Generoso; Márcio Sommer Bittencourt; Raul Dias Santos; Peter P Toth; Stevens R Jones; Isabela M Benseñor; Paulo A Lotufo; Dirce Maria Marchioni Journal: Eur J Nutr Date: 2022-07-27 Impact factor: 4.865
Authors: Arpita Basu; Kenneth Izuora; Nancy M Betts; Jefferson W Kinney; Arnold M Salazar; Jeffrey L Ebersole; R Hal Scofield Journal: Nutrients Date: 2021-04-23 Impact factor: 5.717
Authors: Joel Rodríguez-Saldaña; Francisco Padilla-Padilla; Ernesto G Cardona-Muñoz; Yulia Romero-Antonio; María Marcela Arguedas-Núñez; José G Sander-Padilla; Alberto Martínez-Muñoz; Laura A Lugo-Sánchez; Ileana C Rodríguez-Vazquez; Jorge González-Canudas Journal: Cardiol Res Pract Date: 2022-09-10 Impact factor: 1.990